Spero Therapeutics Reports Q2 2026 Results

What Happened
On August 12, 2026, Spero Therapeutics, Inc. announced its financial results for the second quarter ended June 30, 2026 by issuing a press release. The press release announcing the company’s quarterly results was furnished with the Form 8‑K (Item 2.02) and is attached as Exhibit 99.1.

Key Details

• Filing date: August 12, 2026 (Form 8‑K).
• Reporting period: quarter ended June 30, 2026.
• Press release announcing results furnished as Exhibit 99.1 to the Form 8‑K.
• The report discloses results of operations and financial condition (Item 2.02).

Why It Matters
Quarterly results provide updated information on Spero’s recent revenue, expenses, cash position and operational progress — data investors use to assess near‑term performance and valuation. Because the company furnished a press release via Form 8‑K, investors should review that release (Exhibit 99.1) and any accompanying financial statements or investor materials to see actual earnings, revenue figures, guidance changes or other material updates that could affect the stock.